Summit Investment Advisors »

Lb Pharmaceuticals shares owned by Summit Investment Advisors

Quarter-by-quarter ownership of Lb Pharmaceuticals (LBRX) shares owned by Summit Investment Advisors from 13F filings

Historical chart of Summit Investment Advisors investment in Lb Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lb Pharmaceuticals held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lb Pharmaceuticals by Summit Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $35k 1.6k 22.26

More positions owned by Summit Investment Advisors

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc Class C cs (GOOG)
Ishares Tr Etf (IVV)
Broadcom (AVGO)
Spdr Series Trust Etf (ONEV)
Alphabet Inc Class A cs (GOOGL)
Facebook Inc cl a (META)
Vanguard Europe Pacific ETF (VEA)
Vanguard S&p 500 Etf idx (VOO)
Tesla Motors (TSLA)
iShares Lehman Aggregate Bond (AGG)
iShares S&P 500 Growth Index (IVW)

View all positions for Summit Investment Advisors

Top funds holding Lb Pharmaceuticals

Deep Track Capital
BlackRock
RA Capital Management
TCG Crossover Management
Commodore Capital
Logos Global Management
Vanguard Group
Jpmorgan Chase & Co
Balyasny Asset Management
Jennison Associates
Vivo Capital
Alyeska Investment Group
Nantahala Capital Management
Citadel Advisors
Millennium Management

View all funds holding Lb Pharmaceuticals